Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06695988 · ClinicalTrials.gov registry record · NA
Time-restricted Eating Acceptability, Efficacy and Safety in Obesity
A NA study of Time-restricted Eating, sponsored by University of Mississippi, Oxford.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT06695988: Recruiting NA study of Time-restricted Eating, sponsored by University of Mississippi, Oxford.
NCT06695988 is a NA study of Time-restricted Eating that is actively recruiting participants, run by University of Mississippi, Oxford. The registered enrollment target is 46 participants, below the 112-participant average among 12 other Time-restricted Eating trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06695988, a NA study of Time-restricted Eating, is actively recruiting participants, sponsored by University of Mississippi, Oxford.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized controlled trial to determine adherence, acceptability and safety of time restricted eating (TRE) in healthy, sedentary, free-living adults with obesity between the ages of 19-65 years when following 16:8 TRE for 8 weeks. This 9-week study includes a baseline week and 8 weeks of the intervention period. Participants are randomly assigned to the TRE or the non-fasting control group. The TRE group will consume calorie containing food and drink only over an 8 hour period and rest of the 16 hour would be fasting. Adherence to TRE and calorie intake are the primary outcomes. Motivators, facilitators and barriers to TRE, hunger and cravings levels, weight bias internalization, body composition (weight, body fat%, fat mass and muscle mass) , Healthy Eating Index (HEI) to assess diet quality, skin carotenoid levels, disordered eating risk, sleep quality, and perceptions of health and well-being are secondary outcomes.
Primary Outcome
Percent of days during the 8-week trial when TRE was adhered to as recommended. This will be self-reported daily.
Conditions Studied
Interventions
- BEHAVIORAL Time Restricted Eating
Study Locations (1)
Mississippi
- Department of Nutrition and Hospitality Management, University of Mississippi - Oxford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What NCT06695988 shows while recruiting
NCT06695988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 112-participant average among 12 other Time-restricted Eating trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Time-restricted Eating appearing as the primary indexed condition, and to 1 intervention - of which Time Restricted Eating is the first listed.
NCT06695988 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT06695988 about?
NCT06695988 is a clinical study titled "Time-restricted Eating Acceptability, Efficacy and Safety in Obesity". A randomized controlled trial to determine adherence, acceptability and safety of time restricted eating (TRE) in healthy, sedentary, free-living adults with obesity between the ages of 19-65 years when following 16:8 TRE for 8 weeks. This 9-week study includes a baseline week and 8 weeks of the int...
What is the current status of trial NCT06695988?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2024-06-01. Estimated completion is 2025-10-31.
What conditions does trial NCT06695988 study?
This clinical trial studies the following conditions: Time-restricted Eating.
What interventions are being tested in trial NCT06695988?
The interventions under investigation include: Time Restricted Eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT06695988?
This trial is sponsored by University of Mississippi, Oxford, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06695988 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Time-restricted Eating
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06695988's enrollment target sits among peer trials
46 9th of 12 higher than 4 of 12 other Time-restricted Eating trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Time-restricted Eating trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
RECRUITING · NA
-
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
RECRUITING · NA
-
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
Time-restricted Eating Among Pregnant Females With Severe Obesity
RECRUITING · NA
-
Early vs. Late Time-Restricted Eating in Adolescents With Obesity (EL TREA)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI